TY  - JOUR
AU  - Manchikalapudi, Rama Bindu
PY  - 2017
DA  - 2017/09/28
TI  - Management of Cardiac Allograft Vasculopathy
JO  - OBM Transplantation
SP  - 005
VL  - 01
IS  - 03
AB  - Cardiac allograft vasculopathy(CAV) is one of the leading causes of death following the first 5 years  after orthotopic heart transplantation(OHT) along with late graft failure( likely secondary to undiagnosed CAV.  Currently there is no single medical treatment available for this condition except modification of risk factors and immunosuppression.  Retrasplantation remains the hope for this entity with some limitations.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.1703005
DO  - 10.21926/obm.transplant.1703005
ID  - Manchikalapudi2017
ER  -